Acta Chir Orthop Traumatol Cech. 2025; 92(5):293-297 | DOI: 10.55095/achot2025/026
Revision Arthroplasty for Periprosthetic Femoral Fracture Complicated by Multidrug-Resistant Escherichia coli: Case Report and Minireview
- 1 Ortopedická klinika Fakulty zdravotnických studií Univerzity J. E. Purkyně v Ústí nad Labem a Krajské zdravotní a. s. - Masarykovy nemocnice v Ústí nad Labem, o. z.
- 2 Dětská klinika Fakulty zdravotnických studií Univerzity J. E. Purkyně v Ústí nad Labem a Krajské zdravotní a. s. - Masarykovy nemocnice v Ústí nad Labem, o. z.
- 3 Infekční klinika 3. lékařské fakulty Univerzity Karlovy a Fakultní nemocnice Bu lovka, Praha
Periprosthetic infections caused by multi-resistant bacteria are one of the most fearsome complications in current orthopedics. Despite using aseptic modern practices, the number of infectious complications caused by multidrug-resistant strains is rising worldwide. We present a case of a woman with a non-healing wound after hip arthroplasty revision surgery performed in Egypt for periprosthetic femoral fracture. Upon admission, 11 days after surgery, she presented with a purulent secretion from surgical wound and signs of sepsis. Carbapenem-resistant E. coli was proven from a wound swab. Two-stage revision with a 6-week-long interval of targeted parenteral antibiotic therapy was indicated. During explantation, excessive femoral bone loss after inadequately performed trauma revision surgery was discovered. After antibiotic hip spacer period, the patient underwent implantation of a cemented tumorous revision hip implant followed by 6 weeks of antibiotic therapy. The patient was discharged in more than satisfactory condition, being self-sufficient using French crutches. In follow-up visits during next 2 years, no relapse of carbapenem-resistant infection occurred. In patients hospitalized or operated in high-risk areas, epidemiological anamnesis is of great importance and the possibility of importing multi-resistant bacteria should be considered. Infections caused by these bacteria prolong therapy and increase the cost of treatment significantly. The combination of arthroplasty extraction and targeted antibiotic therapy is recommended to treat periprosthetic infections.
Keywords: hip arthroplasty, arthroplasty revision, periprosthetic fracture, periprosthetic infection, multidrug-resistant E. coli.
Received: March 30, 2025; Revised: March 30, 2025; Accepted: June 14, 2025; Published: December 1, 2025 Show citation
| ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Adams JP, Habenicht D, Ramsey D. Periprosthetic knee infection after benign tumor excision complicated by carbapenem resistant Enterobacteriaceae: a case report. Ann Med Surg (Lond). 2022 Aug 1;81:104292. doi: 10.1016/j.amsu.2022.104292.
Go to original source...
Go to PubMed... - Aggarwal VK, Rasouli MR, Parvizi J. Periprosthetic joint infection: current concept. Indian J Orthop. 2013;47:10-17. doi: 10.4103/0019-5413.106884.
Go to original source...
Go to PubMed... - Ayoade F, Li D, Mabrouk A, Todd JR. Periprosthetic joint infection. 2023. In: StatPearls (Internet). Treasure Island (FL): StatPearls Publishing; 2025.
- Carrër A, Poirel L, Eraksoy H, Cagatay AA, Badur S, Nordmann P. Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey. Antimicrob Agents Chemother. 2008;52:2950-2954. doi: 10.1128/AAC.01672-07.
Go to original source...
Go to PubMed... - Emmer J, Tomáą T, Apostolopoulos V, Brančík P, Rapi J, Nachtnebl L. Mechanical complications and infection control comparison of custom-made and prefabricated articular hip spacers in the treatment of periprosthetic infection. Jt Dis Relat Surg. 2023;34:557-564. doi:10.52312/jdrs.2023.1155.
Go to original source...
Go to PubMed... - European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU/EEA (EARS-Net) - Annual Epidemiological Report 2019. Stockholm: ECDC, 2020.
- Gkavardina A, Tsagozis P. The use of megaprostheses for reconstruction of large skeletal defects in the extremities: a critical review. Open Orthop J. 2014;8:384-389. doi: 10.2174/ 1874325001408010384.
Go to original source...
Go to PubMed... - Gurung S, Kafle S, Dhungel B, Adhikari N, Thapa Shrestha U, Adhikari B, Banjara MR, Rijal KR, Ghimire P. Detection of OXA-48 gene in carbapenem-resistant Escherichia coli and Klebsiella pneumoniae from urine samples. Infect Drug Resist. 2020;13:2311-2321, doi: org/10.2147/IDR.S259967.
Go to original source...
Go to PubMed... - Harrison JJ, Wade WD, Akierman S, Vacchi-Suzzi C, Stremick CA, Turner RJ, Ceri H. The chromosomal toxin gene yafQ is a determinant of multidrug tolerance for Escherichia coli growing in a biofilm. Antimicrob Agents Chemother. 2009;53:2253-2258. doi: 10.1128/AAC.00043-09.
Go to original source...
Go to PubMed... - Jacqueline C, Caillon J. Impact of bacterial biofilm on the treatment of prosthetic joint infections. J Antimicrob Chemother. 2014;69(Suppl 1):i37-40. doi: 10.1093/jac/dku254.
Go to original source...
Go to PubMed... - Michalopoulos AS, Karatza DC. Multidrug-resistant Gram-negative infections: the use of colistin. Expert Rev Anti Infect Ther. 2010;8:1009-1017. doi: 10.1586/eri.10.88.
Go to original source...
Go to PubMed... - Pfang BG, García-Cañete J, García-Lasheras J, Blanco A, Auñón Á, Parron-Cambero R, Macías-Valcayo A, Esteban J. Orthopedic implant-associated infection by multidrug resistant Enterobacteriaceae. J Clin Med. 2019;8:220. doi: 10.3390/jcm8020220.
Go to original source...
Go to PubMed... - Poirel L, Héritier C, Tolün V, Nordmann P. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2004;48:15-22. doi: 10.1128/AAC. 48.1.15-22.2004.
Go to original source...
Go to PubMed... - Rava A, Bruzzone M, Cottino U, Enrietti E, Rossi R. Hip spacers in two-stage revision for periprosthetic joint infection: a review of literature. Joints. 2019;7:56-63. doi: 10.1055/s0039-1697608.
Go to original source... - Rodríguez-Baño J, Gutiérrez-Gutiérrez B, Machuca I, Pascual A. Treatment of infections caused by extended-spect- rum-beta-lactamase-, ampC-, and carbapenemase-producing Enterobacte- riaceae. Clin Microbiol Rev. 2018;31: e00079-17. doi: 10.1128/CMR.00079-17.
Go to original source...
Go to PubMed... - Samelis P V, Papagrigorakis E, Sameli E, Mavrogenis A, Savvidou O, Koulouvaris P. Current concepts on the application, pharmacokinetics and complications of antibiotic-loaded cement spacers in the treatment of prosthetic joint infections. Cureus. 2022;14:e20968. doi:10.7759/cureus.20968.
Go to original source...
Go to PubMed... - Sukeik M, Haddad FS. Periprosthetic joint infections after total hip replacement: an algorithmic approach. SICOT J. 2019;5:5. doi: 10.1051/sicotj/2019004.
Go to original source...
Go to PubMed... - Tomáą T, Apostolopoulos V, Brančík P, Nachtnebl L, Mahdal M. Long-term implant survival, functional, and radiological assessment of cemented stem in revision hip arthroplasty. Int Orthop. 2025;49:1615-1624. doi: 10.1007/s00264-025-06526-z. Epub 2025 Apr 11.
Go to original source...
Go to PubMed... - Tseng WP, Chen YC, Yang BJ, Chen SY, Lin JJ, Huang YH, Fu CM, Chang SC, Chen SY. Predicting multidrug-resistant gram-negative bacterial colonization and associated infection on hospital admission. Infect Control Hosp Epidemiol. 2017;38:1216-1225. doi: 10.1017/ice.2017.178.
Go to original source...
Go to PubMed...


